Pfizer's close-fought contest with GSK to bring a next-generation meningitis vaccine to market has entered the final rounds, with the former ahead on points following the readout of a pivot
Will Moore examines the reaction of the public and healthcare providers to the high-profile news of a two-year-old who died from Meningitis B infection and subsequent demands for more widesprea
